BackSorrento Therapeutics Overview

Sorrento Therapeutics Cost of Revenue

Cost of Revenue analysis for SRNE.

Quarterly Cost of Revenue

$8.45M
↑ 48.19% YoY

As of Jun 30, 2023

Annual Cost of Revenue (TTM)

$35.63M
↑ 98.09% YoY

Trailing 12 months ending Jun 30, 2023

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin